Error: Could not add to watchlist. X

GTx Inc

+ Watchlist
GTXI:US
NASDAQ CM
1.52
USD
0.05
3.18%
As of 10:41:17 ET on 07/06/2015.
Open
1.56
Day Range
1.45 - 1.56
Volume
64,054
Previous Close
1.57
52Wk Range
0.41 - 1.59
1 Yr Return
4.83%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.36
Market Cap (m USD)
211.965
Shares Outstanding (m)
140.374
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.
ADDRESS
175 Toyota Plaza
7th Floor
Memphis, TN 38103
United States
PHONE
1-901-523-9700
  • Robert J Wills "Rob"
    Chairman
  • Marc S Hanover
    President/CEO/COO/Co-Founder
  • Henry P Doggrell
    VP/Chief Legal Officer/Secy
  • Jeffrey G Hesselberg
    VP:Regulatory Affairs
  • Mary Ann Johnston
    VP:Medical Affairs
Show More